These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Human pathology in NCL. Anderson GW; Goebel HH; Simonati A Biochim Biophys Acta; 2013 Nov; 1832(11):1807-26. PubMed ID: 23200925 [TBL] [Abstract][Full Text] [Related]
3. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect. de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383 [TBL] [Abstract][Full Text] [Related]
4. A variant form of late infantile neuronal ceroid lipofuscinosis (CLN5) is not an allelic form of Batten (Spielmeyer-Vogt-Sjögren, CLN3) disease: exclusion of linkage to the CLN3 region of chromosome 16. Williams R; Santavuori P; Peltonen L; Gardiner RM; Järvelä I Genomics; 1994 Mar; 20(2):289-90. PubMed ID: 8020979 [TBL] [Abstract][Full Text] [Related]
5. Molecular genetic analysis of neuronal ceroid lipofuscinosis. Mole SE; Gardiner M Int J Neurol; 1991-1992; 25-26():52-9. PubMed ID: 11980063 [TBL] [Abstract][Full Text] [Related]
7. Linkage analysis of late-infantile neuronal ceroid-lipofuscinosis. Sharp J; Savukoski M; Wheeler RB; Harris J; Järvelä I; Peltonen L; Gardiner M; Williams R Am J Med Genet; 1995 Jun; 57(2):348-9. PubMed ID: 7668361 [TBL] [Abstract][Full Text] [Related]
8. Genetic linkage analysis of a variant of juvenile onset neuronal ceroid lipofuscinosis with granular osmiophilic deposits. O'Rawe A; Mitchison HM; Williams R; Wheeler R; Andermann E; Andermann F; Hart YM; Martin JJ; Philippart M; Stephenson JB; Gardiner RM; Mole SE Neuropediatrics; 1997 Feb; 28(1):21-2. PubMed ID: 9151314 [TBL] [Abstract][Full Text] [Related]
9. Atypical late infantile and juvenile forms of neuronal ceroid lipofuscinosis and their diagnostic difficulties. Wiśniewski KE; Zhong N; Kida E; Kaczmarski W; Kaczmarski A; Connell F; Brooks SS; Brown WT Folia Neuropathol; 1997; 35(2):73-9. PubMed ID: 9377079 [TBL] [Abstract][Full Text] [Related]
10. A novel c.776_777insA mutation in CLN1 leads to infantile neuronal ceroid lipofuscinosis. Miller JN; Pearce DA J Child Neurol; 2013 Sep; 28(9):1106-11. PubMed ID: 23857568 [TBL] [Abstract][Full Text] [Related]
11. Molecular genetics of the neuronal ceroid lipofuscinoses. Mole S; Gardiner M Epilepsia; 1999; 40 Suppl 3():29-32. PubMed ID: 10446748 [TBL] [Abstract][Full Text] [Related]
12. Genetic heterogeneity in neuronal ceroid lipofuscinosis (NCL): evidence that the late-infantile subtype (Jansky-Bielschowsky disease; CLN2) is not an allelic form of the juvenile or infantile subtypes. Williams R; Vesa J; Järvelä I; McKay T; Mitchison H; Hellsten E; Thompson A; Callen D; Sutherland G; Luna-Battadano D Am J Hum Genet; 1993 Oct; 53(4):931-5. PubMed ID: 8213822 [TBL] [Abstract][Full Text] [Related]
13. Hippocampal lesions in the neuronal ceroid lipofuscinoses. Haltia M; Herva R; Suopanki J; Baumann M; Tyynelä J Eur J Paediatr Neurol; 2001; 5 Suppl A():209-11. PubMed ID: 11588999 [TBL] [Abstract][Full Text] [Related]
18. Accumulation of sphingolipid activator proteins (SAPs) A and D in granular osmiophilic deposits in miniature Schnauzer dogs with ceroid-lipofuscinosis. Palmer DN; Tyynelä J; van Mil HC; Westlake VJ; Jolly RD J Inherit Metab Dis; 1997 Mar; 20(1):74-84. PubMed ID: 9061571 [TBL] [Abstract][Full Text] [Related]
19. Neuronal ceroid lipofuscinosis: an ultrastructural, genetic, and clinical study report. Boldrini R; Biselli R; Santorelli FM; Bosman C Ultrastruct Pathol; 2001; 25(1):51-8. PubMed ID: 11297320 [TBL] [Abstract][Full Text] [Related]